Munich - Delayed Quote EUR
Agenus Inc (AJ8.MU)
2.5800
+0.1000
+(4.03%)
At close: April 25 at 3:41:20 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
103,463
103,463
156,314
98,024
295,665
Cost of Revenue
156,014
156,014
237,680
197,259
182,078
Gross Profit
-52,551
-52,551
-81,366
-99,235
113,587
Operating Expense
71,878
71,878
78,739
81,007
76,359
Operating Income
-124,429
-124,429
-160,105
-180,242
37,228
Net Non Operating Interest Income Expense
-117,626
-117,626
-97,925
-61,863
-65,719
Other Income Expense
9,784
9,784
593
11,449
-233
Pretax Income
-232,271
-232,271
-257,437
-230,656
-28,724
Net Income Common Stockholders
-227,427
-227,427
-245,974
-220,286
-24,137
Diluted NI Available to Com Stockholders
-227,427
-227,427
-245,974
-220,286
-24,137
Basic EPS
-10.59
--
-13.75
-15.64
-2.20
Diluted EPS
-10.59
--
-13.75
-15.64
-2.20
Basic Average Shares
21,473
--
17,894
14,087
11,445.9500
Diluted Average Shares
21,473
--
17,894
14,087
11,445.9500
Total Operating Income as Reported
-120,475
-120,475
-159,549
-179,427
25,747
Total Expenses
227,892
227,892
316,419
278,266
258,437
Net Income from Continuing & Discontinued Operation
-227,212
-227,212
-245,761
-220,074
-23,926
Normalized Income
-231,166
-231,166
-246,317
-218,952
-18,642
Interest Expense
117,626
117,626
97,925
61,863
65,719
Net Interest Income
-117,626
-117,626
-97,925
-61,863
-65,719
EBIT
-114,645
-114,645
-159,512
-168,793
36,995
EBITDA
-101,302
-101,302
-145,924
-161,847
43,783
Reconciled Cost of Revenue
156,014
156,014
237,680
197,259
182,078
Reconciled Depreciation
13,343
13,343
13,588
6,946
6,788
Net Income from Continuing Operation Net Minority Interest
-227,212
-227,212
-245,761
-220,074
-23,926
Total Unusual Items Excluding Goodwill
3,954
3,954
556
-1,122
-5,284
Total Unusual Items
3,954
3,954
556
-1,122
-5,284
Normalized EBITDA
-105,256
-105,256
-146,480
-160,725
49,067
12/31/2021 - 8/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
YB4P.SG Savara Inc
2.7600
-2.82%
BVNKF Bavarian Nordic A/S
23.07
0.00%
VRAX Virax Biolabs Group Limited
1.0500
-3.67%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.3700
+0.74%
SVRA Savara Inc.
3.1800
-2.75%
TECX Tectonic Therapeutic, Inc.
21.09
-5.76%
LYRA Lyra Therapeutics, Inc.
0.1050
+5.95%
CLSD Clearside Biomedical, Inc.
0.8417
-0.80%
CRDF Cardiff Oncology, Inc.
2.8800
-0.69%
GOVX GeoVax Labs, Inc.
0.9768
-2.32%